Somaia Mohamed Selected Research

Antidepressive Agents (Antidepressants)

1/2020	Impact of Concurrent Posttraumatic Stress Disorder on Outcomes of Antipsychotic Augmentation for Major Depressive Disorder With a Prior Failed Treatment: VAST-D Randomized Clinical Trial.
3/2018	Antipsychotic Prescriptions Among Adults With Major Depressive Disorder in Office-Based Outpatient Settings: National Trends From 2006 to 2015.
7/2017	Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial.
9/2016	Initiation of pharmacotherapy for post-traumatic stress disorder among veterans from Iraq and Afghanistan: a dimensional, symptom cluster approach.
10/2015	The VA augmentation and switching treatments for improving depression outcomes (VAST-D) study: Rationale and design considerations.
4/2013	Adding antidepressants to antipsychotics for treatment of subsyndromal depressive symptoms in schizophrenia: Impact on positive and negative symptoms.
1/2012	Does antidepressant treatment improve cognition in older people with schizophrenia or schizoaffective disorder and comorbid subsyndromal depression?
6/2009	Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
4/2009	Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial.
10/2008	Pharmacologic treatment of posttraumatic stress disorder among privately insured Americans.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Somaia Mohamed Research Topics

Disease

15	Schizophrenia (Dementia Praecox) 07/2015 - 01/2005
8	Psychotic Disorders (Schizoaffective Disorder) 01/2017 - 12/2007
7	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020 - 12/2005
7	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 10/2008
3	Mental Disorders (Mental Disorder) 09/2009 - 08/2006
3	Anxiety Disorders (Anxiety Disorder) 09/2009 - 06/2008
2	Psychomotor Agitation (Akathisia) 07/2017 - 12/2007
2	Syndrome (Syndromes) 09/2016 - 12/2007
2	Bipolar Disorder (Manic Depressive Psychosis) 09/2009 - 10/2008
1	Weight Gain 07/2017
1	Sleepiness 07/2017
1	Substance-Related Disorders (Drug Abuse) 07/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2012
1	Tardive Dyskinesia 01/2011
1	Dementia (Dementias) 09/2009
1	Movement Disorders (Movement Disorder) 04/2009
1	Dysthymic Disorder 10/2008
1	Depressive Disorder (Melancholia) 06/2008

Drug/Important Bio-Agent (IBA)

17	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 01/2005
11	Antidepressive Agents (Antidepressants)IBA 01/2020 - 06/2008
4	Aripiprazole (Abilify)FDA Link 01/2020 - 06/2009
4	Risperidone (Risperdal Consta)FDA LinkGeneric 07/2015 - 09/2009
4	Silver Sulfadiazine (SSD)FDA LinkGeneric 04/2013 - 12/2007
3	Bupropion (Wellbutrin)FDA LinkGeneric 01/2020 - 10/2015
3	Anti-Anxiety Agents (Anxiolytics)IBA 09/2016 - 06/2008
3	Hypnotics and Sedatives (Sedatives)IBA 09/2016 - 06/2008
3	Pharmaceutical PreparationsIBA 07/2015 - 03/2009
3	Quetiapine Fumarate (Seroquel)FDA Link 07/2015 - 09/2009
3	Citalopram FDA LinkGeneric 04/2013 - 04/2009
2	Olanzapine (Zyprexa)FDA Link 07/2015 - 01/2011
2	Perphenazine (Trilafon)FDA LinkGeneric 07/2015 - 01/2011
2	ziprasidone (Geodon)FDA Link 07/2015 - 01/2011
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2017
1	Prazosin (Minipress)FDA LinkGeneric 09/2016
1	Nicotine FDA Link 07/2015

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 09/2016 - 06/2008
2	Therapeutics 08/2006 - 12/2005
1	Injections 12/2009
1	Duration of Therapy 12/2009
1	Off-Label Use 09/2009